More importantly, the subset of LUAD with co-mutation of FAT3 and LRP1B exhibited significantly prolonged immunotherapy PFS, so we performed GSEA and immune infiltration analysis on this subset to explore the effect of co-mutation on the degree of lymphocyte infiltration and tumorigenesis in lung adenocarcinoma. The gene discussed is LRP1B; the disease is lung adenocarcinoma.